title: Validation of EGCRISC for Chronic Hepatitis C Infection Screening and Risk Assessment in the Egyptian Population.
abstract: Chronic HCV infection, a highly endemic disease in Egypt, is usually asymptomatic for decades after infection. Prediction questionnaire tool was proofed to be a valuable, feasible and efficient instrument for the screening of several diseases. We previously developed an Egyptian HCV risk screening tool (EGCRISC). This study aims to validate/modify EGCRISC. A cross-sectional study testing 4579 individuals by EGCRISC as well as ELISA/PCR was performed. The sample was a stratified cluster sampling from urban and rural areas in Upper and Lower Egypt using a proportional allocation technique. The degree of agreement and positive and negative posttest probabilities were calculated. ROC curve was done and the cutoff points were customized for best performance. The total score was further classified into three levels according to the risk load. The mean age of the participants was 41.1±12.2 in whom HCV prevalence was 8.6%. EGCRISC, particularly after modifying the cutoff points, has a good discriminating ability. The degree of agreement was at least 68.1% and the positive posttest probability ranged from 5% to 37.2% whereas the negative posttest probability was in the range 1% to 17%. We conclude that EGCRISC is a valid tool that can potentially screen for HCV infection risk in Egypt and could diminish the demand for mass serologic screening in those apparently at minimal risk. Extensive use of electronic and self- or interviewer-administered risk-based screening strategy may simplify and promote overall screening and detection of HCV dissimilar communities.
authors.affiliation: Tropical Health Department, High Institute of Public Health, Alexandria University, Egypt.
authors.forename: Engy Mohamed
authors.initials: EM
authors.lastname: El-Ghitany
authors.affiliation: Tropical Health Department, High Institute of Public Health, Alexandria University, Egypt.
authors.forename: Azza Galal
authors.initials: AG
authors.lastname: Farghaly
authors.affiliation: Biostatistics Department, High Institute of Public Health, Alexandria University, Egypt.
authors.forename: Shehata
authors.initials: S
authors.lastname: Farag
authors.affiliation: Tropical Health Department, High Institute of Public Health, Alexandria University, Egypt.
authors.forename: Ekram Wassim
authors.initials: EW
authors.lastname: Abd El-Wahab
mesh_terms: D000328:Adult; D000914:Antibodies, Viral / Q000032:analysis; D019540:Area Under Curve; D003430:Cross-Sectional Studies; D003710:Demography; D004534:Egypt / Q000453:epidemiology; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D016174:Hepacivirus / Q000235:genetics / Q000276:immunology / Q000302:isolation & purification; D019698:Hepatitis C, Chronic / Q000175:diagnosis* / Q000453:epidemiology; D006801:Humans; D008297:Male; D008403:Mass Screening / Q000379:methods*; D008875:Middle Aged; D016017:Odds Ratio; D016133:Polymerase Chain Reaction; D015995:Prevalence; D012367:RNA, Viral / Q000097:blood / Q000378:metabolism; D012372:ROC Curve; D018570:Risk Assessment
chemical_list: D000914:Antibodies, Viral; D012367:RNA, Viral